AdiPearl
Phase 1- Indications
- Soft tissue reconstruction
Company intelligence / Profile preview
Volumina Medical has developed AdiPearl™, an injectable hydrogel-based biomaterial designed for minimally invasive soft tissue reconstruction. The company has completed preclinical and initial clinical studies demonstrating exceptional performance. Their lead product targets breast reconstruction post-cancer surgery as well as other reconstructive/aesthetic indications. They have secured significant funding following successful first-in-human trials and are advancing through further clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Volumina Medical.